Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 27.05.2008 – 13:05

    Isotechnika Inc.

    Isotechnika Reports Final Results of the PROMISE Trial

    Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) today announced positive results from the Phase 2b PROMISE trial which evaluated the Company's lead drug, voclosporin , in de novo kidney transplant patients. This trial was designed to determine the most appropriate dosing strategy for the Phase 3 program in kidney transplantation. "PROMISE has shown that the efficacy of voclosporin is statistically ...

  • 26.05.2008 – 14:32

    Mawson Resources Ltd.

    Mawson Drills 16 Metres of 209 ppm U3O8 at Tasjo, Sweden

    Vancouver, British Columbia (ots/PRNewswire) - Mawson Resources Limited ("Mawson") TSX - MAW; Frankfurt - MRY. Michael Hudson, President & CEO, announces the first results from the Company's 40 hole, 1,724 metre winter diamond drill program at the Tasjo uranium - rare earth element (REE) - phosphate project in Sweden. Results are available for the first 8 holes (BODDD08001 to BODDD08004, BODDD08007, BODDD08013 and ...

  • 26.05.2008 – 12:06

    ICS Copper Systems Ltd

    ICS Copper Systems Ltd Announces CAD$1.1 Million Private Placement

    Abbotsford, British Columbia (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) reports that it has arranged a private placement of 2,750,000 units at a price of CAD$0.40 per Unit for gross proceeds of CAD$1,100,000. Each Unit will consist of one common share and one full warrant entitling the holder to purchase a common share at a price of CAD$0.50 for a period of 24 months after closing. Completion of the ...

  • 26.05.2008 – 07:04

    Amsterdam Molecular Therapeutics B.V

    AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity

    Amsterdam, The Netherlands (ots/PRNewswire) - - Production Increase Brings Large Disease Areas Within Reach Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a Cooperative Research and Development Agreement from the National Heart, Lung, and Blood Institute (NHLBI) of the National ...

  • 25.05.2008 – 12:47

    University of Massachusetts Medical School

    Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World

    Barcelona, Spain (ots/PRNewswire) - - In Europe, Less Screening and Treatment, and an Apparent Higher Prevalence of Hip Fracture Than in North America and Australia In a first-of-its-kind study in osteoporosis, one in four women surveyed from Europe, North America, and Australia reported having one or more bone fractures since the age of 45 years. Among ...

  • 19.05.2008 – 09:04

    Roche Pharmaceuticals

    "Am I Number 12?"

    Basel, Switzerland (ots/PRNewswire) - - Roche Supports Patient Groups and International Health Bodies to Call for Increased Resources to Fight Viral Hepatitis - a Major Global Killer A staggering one in 12 people globally are estimated to be infected with chronic hepatitis B or C - this equates to around 500 million people worldwide.(1,2) What is even more alarming is that in some European countries up to 98% of people infected with viral hepatitis and have not ...

  • 16.05.2008 – 18:57

    CEVA Logistics

    CEVA Group Plc Announces the Release of its Quarter 1 2008 Results

    Hoofddorp, Netherlands (ots/PRNewswire) - CEVA Group Plc will publish its Quarter 1 2008 results on Friday, May 23, 2008. The Interim Financial Statement will be made available on CEVA's website http://www.cevalogistics.com at 09:00 GMT. A press release with the highlights of the Report will be issued the same date. CEVA. Making Business Flow CEVA Logistics ...

  • 16.05.2008 – 12:52

    Orange

    Orange Brings the iPhone to Customers in Europe, Middle East and Africa

    Paris (ots/PRNewswire) - Orange today announced a new agreement with Apple to bring the iPhone to Orange customers in Austria, Belgium, the Dominican Republic, Egypt, Jordan, Poland, Portugal, Romania, Slovakia, Switzerland and Orange's African markets later this year. About Orange Orange is the key brand of France Telecom, one of the world's leading ...

  • 16.05.2008 – 07:04

    Abbott Laboratories

    Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System

    Abbott Park, Illinois (ots/PRNewswire) - - New Device Designed to Provide Fast, Safe and Secure Vessel Closure Following Catheterization Procedures Abbott today announced the launch of the StarClose(R) SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast, safe and secure closure of the femoral artery access site ...